Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/107921
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRachul, C.en
dc.contributor.authorToews, M.en
dc.contributor.authorCaulfield, T.en
dc.date.issued2016en
dc.identifier.citationJournal of Cystic Fibrosis, 2016; 15(5):624-629en
dc.identifier.issn1569-1993en
dc.identifier.urihttp://hdl.handle.net/2440/107921-
dc.description.abstractAbstract not availableen
dc.language.isoenen
dc.publisherElsevieren
dc.rightsChristen Rachul, Maeghan Toews, Timothy Caulfielden
dc.subjectKalydeco; orphan drug; Venture philanthropy; drug reimbursement; patient accessen
dc.titleControversies with Kalydeco: newspaper coverage in Canada and the United States of the cystic fibrosis "Wonder Drug"en
dc.typeJournal articleen
dc.identifier.rmid0030066468en
dc.identifier.doi10.1016/j.jcf.2016.03.006en
dc.identifier.pubid290611-
pubs.library.collectionLaw publicationsen
pubs.library.teamDS14en
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
Appears in Collections:Law publications

Files in This Item:
File Description SizeFormat 
RA_hdl_107921.pdfRestricted Access308.43 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.